Skip to content

decrease of side effect of chemotherapy by continuous care model

The effect of continuous care model on the side effect of chemotherapy in breast cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013070613802N2
Enrollment
74
Registered
2013-09-25
Start date
2013-07-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer. Malignant neoplasm of Breast

Interventions

Intervention 1: intervention group: Continuous Care Model (Including orientation, sensitization, monitoring and evaluation) in the intervention group and measurements related to sleep, fatigue, pain,n
Prevention
intervention group: Continuous Care Model (Including orientation, sensitization, monitoring and evaluation) in the intervention group and measurements related to sleep, fatigue, pain,nasea and body im
control group: in the control group the patients will be received only routine cares

Sponsors

Ahvaz Jundishapor University Of Medical Sceinces
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Being aware of the time and place; The lack of a clear and well-known sleep disorders, pain, fatigue, nausea and vomiting in the patient's medical history is mentioned; Lack of mental and brain diseases in the patient's medical history is mentioned (Thease has the effect of variables);The absence of severe dyspnea in patients; Not receiving the sleep-disrupting drugs such as diuretic drugs, antidepressants, and amphetamines and inotropes at night; Age 65-25 years; known Persian language; Patients who have a minimum of one and a maximum of 5 sessions of chemotherapy; Patients with stage II, III and IV disease. Exclusion criteria: Get an anesthetic and narcotic drugs during the study; Patient's unwillingness to continue participation in the study; Acute complications during the study; Get the sleep-disrupting drugs such as diuretic drugs, antidepressants, and amphetamines and inotropes at night; Need CPR during the intervention

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sleep quality. Timepoint: beginning of study, two months after intervention. Method of measurement: pittsburgh sleep quality Questionnaire.;Pain. Timepoint: beginning of study, two months after intervention. Method of measurement: pain assessment questionnaire.;Fatigue. Timepoint: beginning of study, two months after intervention. Method of measurement: fatigue summarized check list.;Nasea. Timepoint: beginning of study, two months after intervention. Method of measurement: nasea assessment questionnaire.;Body image. Timepoint: beginning of study, two months after intervention. Method of measurement: Body image scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Imanian

Ahvaz Jundishapor University Of Medical Sceinces

mahsa.imanian@gmail.com imanian.m@ajums.ac.ir+98 79 1227 7642

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026